High-throughput, automated, and accurate biochemical screening for pheochromocytoma: Are we there yet?

Clinical Chemistry

Volumn 53, Issue 9, 2007, Pages 1565-1567

  Singh, Ravinder J ^a   Eisenhofer, Graeme ^b  

^a MAYO CLINIC   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; METADRENALIN; NORADRENALIN;

DIAGNOSTIC ACCURACY; EDITORIAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHEOCHROMOCYTOMA; SIGNAL NOISE RATIO; SOLID PHASE EXTRACTION;

ADRENAL GLAND NEOPLASMS; AUTOANALYSIS; HUMANS; METANEPHRINE; PHEOCHROMOCYTOMA; TANDEM MASS SPECTROMETRY;

EID: 34548303452     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.089128     Document Type: Editorial

References (14)

1. de Jong WHA, Graham KS, van der Molen JC, Links TP, Morris MR, Ross HR, et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC-tandem mass spectrometry. Clin Chem 2007: 1684-93.
2. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 2004;56:331-49.
3. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 2007;3:92-102.
4. Lagerstedt SA, O'Kane DJ, Singh RJ. Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem 2004;50: 603-11.
5. Singh RJ. Advances in metanephrine testing for the diagnosis of pheochromocytoma. Clin Lab Med 2004;24:85-103.
6. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49: 1041-4.
7. Manz B, Kuper M, Booltink E, Fischer-Brugge U. Development of enantioselective immunoassays for free plasma metanephrines. Ann N Y Acad Sci 2004;1018:582-7.
8. Lenz T, Zorner J, Kirchmaier C, Pillitteri D, Badenhoop K, Bartel C, et al. Multicenter study on the diagnostic value of a new RIA for the detection of free plasma metanephrines in the work-up for pheochromocytoma. Ann N Y Acad Sci 2006;1073:358-73.
9. Unger N, Pitt C, Schmidt IL, Walz MK, Schmid KW, Philipp T, et al. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 2006;154:409-17.
10. Singh RJ, Grebe SK, Yue B, Rockwood AL, Cramer JC, Gombos Z, et al. Precisely wrong? Urinary fractionated metanephrines and peer-based laboratory proficiency testing. Clin Chem 2005;51:472-3.
11. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, et al. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 2005; 90:2068-75.
12. Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, et al. Neuroblastoma screening at one year of age. N Engl J Med 2002;346: 1047-53.
13. Lenders JW, Willemsen JJ, Eisenhofer G, Ross HA, Pacak K, Timmers HJ, et al. Is supine rest necessary before blood sampling for plasma metanephrines? Clin Chem 2007;53:352-4.
14. Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM, et al. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 2005;51:735-44.